USNA Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

03
Fiyat $14.82
Piyasa Değeri (MRQ) $274M
P/E (TTM) -7.1
Hisse Başına Kâr (TTM) $-2.10
Gelir (TTM) $927M
ROE (TTM) -7.4%
52 Haftlık Aralık $13–$27

USNA Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

04
aralık
çubuklar

Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.

Hisse bölünmeleri 3
Ex-tarihi Bölünme Tür
23 Kasım 2016 2-for-1 İleri
31 Ekim 2003 2-for-1 İleri
04 Ağustos 1998 2-for-1 İleri

USANA Health Sciences, Inc. Common Stock Hakkında Wikipedia'dan şirket genel bakışı

05 · wikidata

USANA Health Sciences, Inc., or USANA, is an American direct sales company based in Salt Lake City, Utah. As of 2021, USANA was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 25 countries via a network of independent distributors.

History

In 1992, immunologist and microbiologist Myron Wentz moved his diagnostic testing company, Gull Laboratories, from Salt Lake City to West Valley City, Utah, and spun it into USANA Health Services, a multilevel marketing manufacturer of supplements. Beginning in 1993, Dallin A. Larsen served as USANA's vice president of sales (and later as a consultant to USANA's president and special advisor to the board of directors) before founding the MLM beverage company Monavie in 2005. USANA's products are not available through retail channels, and can only be obtained through one of its brand partnersor by direct order through the company.

On 20 February 2007, Barry Minkow, founder of the Fraud Discovery Institute, distributed a 500-page report to officials at the U.S. Securities and Exchange Commission (SEC), the Federal Bureau of Investigation (FBI), and the Internal Revenue Service (IRS) accusing USANA of operating an illegal pyramid scheme. The SEC conducted an investigation into USANA's business practices in March 2007 and found no evidence of wrongdoing, concluding its inquiry with no enforcement action recommended. Minkow acknowledged that he was shorting USANA's shares, hoping to profit from a drop in the stock price. In April 2007, a class action lawsuit was filed alleging that USANA's common stock had been artificially inflated. In August 2007, USANA was notified by the Securities and Exchange Commission (SEC) that its shares were subject to delisting from the NASDAQ due to its Form 10-Q, and was determined to be in compliance that October.

In January 2008, a shareholder suit was filed with allegations that USANA had misled investors about the sustainability of its growth and business model. The cases were dismissed, and the company was cleared by the U.S. Securities and Exchange Commission after an informal inquiry into the allegations, stating that it did "not intend to recommend any enforcement action by the Commission." Later that year, two Canadian USANA distributors were awarded $7 million in damages for their wrongful dismissal from the company. The firm had terminated their positions in 2003 because it believed the distributor had violated the companies' policies and procedures.

USANA filed suits against Minkow and his company claiming defamation and stock manipulation. USANA dropped the defamation suit and in March 2008 U.S. District Judge Tena Campbell threw out four of the five claims brought by USANA against Minkow ruling that USANA's claims violated California's anti-SLAPP law for suing Minkow for fair criticism and that USANA did not show a reasonable probability of winning on those claims. The remaining charge of stock manipulation was settled in July 2008, when USANA and Minkow reached an undisclosed settlement that included the removal of all USANA-related materials from the Fraud Discovery Institute website, a related Chinese website, and YouTube. Minkow also agreed to never trade in USANA's stock again.

In December 2010, USANA completed the application process to transfer its common stock listing from the NASDAQ National Market System, where it had traded since 1996, to the New York Stock Exchange. The transfer became official at the beginning of 2011. It received drug-establishment registration from the Food and Drug Administration to manufacture over-the-counter drugs later that year. In 2012, 91% of product sales were purchased by associates. The company acquired BabyCare Ltd., a China-based prenatal supplement company, in 2013 and announced plans to build a manufacturing facility in the country.

By 2018, USANA had reported record revenue due to growth in the Asia-Pacific region, though it recorded a 7% drop in net sales during its 2019 annual report. USANA has partnered with HealthCorps on health education for children and, in 2019, the USANA Foundation's Kids Eat program opened a facility to pack and distribute food for childhood hunger in the Utah area. In 2026, the Kids Eat program continued efforts to address childhood food insecurity in Utah by providing food bags to students and allowing businesses, families, and other organizations to sponsor participating schools. It was also announced as the official nutritional partner of the Spartan Race endurance brand in the United States. Its sales for the first quarter of 2020 declined by 2.3 percent compared with 2019 numbers.

The USANA Foundation was founded in 2012 and has provided hundreds of millions of meals in more than 45 countries. Their programs include USANA Kids Eat and the USANA Garden Towers.

In February 2019, the Ministry of Commerce in China suspended operations of all multi-level marketing companies and participants to conduct a 100-day review of the country's health foods industry due to exaggerated advertising claims and questionable products in the unregulated sector. Chinese departments initiated "Hundred Days of Action" to clean up the health market, where 49 products from various companies were revoked, 54 food business licenses of various companies were revoked, 90 business licenses of various companies were revoked, and 465 counterfeit and fake dens were destroyed. 85 companies, including BabyCare Ltd., a USANA subsidiary, signed a declaration to self-discipline and regulate operations, with BabyCare speaking at an event hosted by the Chinese government.

In 2024, USANA acquired a 79% stake in children's health and wellness company Hiya Health in a $260 million transaction, making Hiya a subsidiary of USANA. At the time of the acquisition, Hiya had grown to approximately $100 million in annual sales and offered eight children's health products, including multivitamins, probiotics, iron supplements, and immune support products.

Corporate affairs

Leadership

In 2007, USANA faced repeated controversy after members of its board of directors, medical advisory board and several of its executives made false statements regarding their qualifications, including education and licenses.

Founder Myron Wentz was the company's chief executive officer from 1992 until 2008, when his son, Dave Wentz, succeeded him after working in positions such as president, executive vice president, and senior vice president of strategic development. In 2015, USANA announced that the chief executive officer role would be divided between Wentz and Kevin Guest, with the former taking global operations and the latter, field development and sales. Guest was appointed the sole chief executive officer in November 2016.

Operations

USANA, a multilevel marketing company, sells its products primarily through non-employee Brand Partners, as well as through the Internet. The firm's 2010 income disclosure statement defines "associates" as those who are actively building a business, acting as wholesale buyers, or are new distributors. The firm's 2009 SEC 10-K filing distinguishes between associates and preferred customers. Associates are independent distributors of USANA products and also purchase them for personal use. Preferred customers may purchase products at wholesale prices strictly for personal use and are not permitted to resell or distribute them. As of July 2011, the firm had 222,000 active Associates and 68,000 preferred customers. It manufactured 90% of its products at the Salt Lake City headquarters, which produced more than 22 million tablets each week.

Associates may be eligible to receive commissions based on their own product sales as well as through sales made by any new distributors they recruit. According to documentation from USANA corporate, 87 percent of associates fail to make enough from commissions to recover the cost of their qualifying purchases with 67 percent of all associates making no commission; the top 2.31 percent of associates earns 72.2 percent of the company's commissions. According to a 2011 article published by the Salt Lake City Tribune, the firm's FY09 income disclosure statement indicated that the average yearly income of the company's 165,710 associates, which includes those just starting, was $617, while the "top-of-the-pyramid distributors earn an average of $857,865 annually".

USANA sells nutritional, personal care, and food products through Brand Partners and online channels.

USANA classifies Brand Partners and Preferred Customers in its core nutritional business as active customers. There were 387,000 active customers as of January 2026. In 2025, Brand Partners and Preferred Customers each made up about half of all active customers.

Sponsorships

USANA has been a paid sponsor of various athletic organizations. USANA offers an "Athlete Guarantee Program" to select sponsored athletes. The program permits selected participants to enter into an agreement with the company stipulating that, should an athlete enrolled in the program test positive for a banned substance (included in World Anti-Doping Agency regulations) as a result of taking USANA products, the company will compensate the athlete up to two times his or her current annual earnings up to $1 million USD.

In 2006, USANA signed a co-sponsorship agreement with the WTA Tour and extended it in 2011. The agreement provides athletes with nutritional supplements that are guaranteed to conform to the Tour's antidoping policy. As part of the agreement in 2011, USANA donated $1 to Children's Hunger Fund for every ace scored at a WTA tournament beginning at Wimbledon and continuing through the end of the season. USANA provided its products to 40 athletes at the Turin Olympics and worked with various sports organizations, including the Professional Rodeo Cowboys Association.

In 2003, USANA became the title sponsor of the USANA Amphitheatre, an outdoor amphitheatre based in West Valley City, Utah with a seating capacity of 20,000. In May 2012, United Concerts announced a continued naming rights partnership with USANA Health Sciences through March 2018.

In 2020, USANA became the title partner of U.S. Ski & Snowboard's training and education facility, the Center of Excellence. The facility is a training hub used by Olympians, youth athletes, and various international competitions.

In the lead-up to the 2020 Summer Olympics, USANA announced partnerships with USA Swimming and the USA Skateboarding National Team. It was the official multivitamin sponsor of USA Swimming and official nutritional supplement supplier of USA Skateboarding. The partnerships reportedly extended into multi-year agreements.

Products

USANA produces three product lines: USANA Nutritionals (Cellsentials, Optimizers, and Digestion/Detox nutritional supplements), USANA Diet & Energy (Reset meal replacement shakes, protein bars, and Rev3 energy drinks), and Sensé & Celavive personal care (skin care, skin treatment, and hair & body care products).

USANA Essentials were tested in 2011 by ConsumerLab.com in its Multivitamin and Multimineral Supplements Review of 38 leading multivitamin/multimineral products sold in the U.S. and Canada. The Essentials passed ConsumerLab's test, which included testing of selected index elements, their ability to disintegrate in solution per United States Pharmacopeia guidelines, lead contamination threshold set in California Proposition 65, and meeting U.S. Food and Drug Administration (FDA) labeling requirements.

USANA began using InCelligence Technology in August 2016 and registered it as a U.S. trademark in March 2017. The technology is used in the company's CellSentials nutritional supplement system, including its Core Minerals and Vita-Antioxidant products, which USANA markets as using its InCelligence Complex to support cellular protection and renewal. As of 2019, its products are marketed in the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands, the United Kingdom, the Caribbean, Puerto Rico, Philippines, France, China, Spain, Italy, Germany, Romania, Denmark, Colombia and Indonesia.

Reception

From 2004 to 2006, USANA was named on Forbes "200 Best Small Companies" list. In 2007, a Forbes article quoted industry experts and government officials who had raised questions about the cost of USANA's supplements and its business practices. Radio-Canada later aired an investigative report that examined the company's products, pricing and "misleading income claims" made to potential associates concerning revenue. It included hidden-camera footage of recruitment and other sessions, which found one group of associates appeared to violate the company's policies and distributor agreements. This contrasted with the Canadian legal requirements for multi-level marketing companies to provide clear, frequent and complete information about the revenue of the typical participant. In addition, the same group of associates were filmed making recommendations for using USANA products to treat illnesses including leukemia.

John Cloud, senior writer for Time Magazine, evaluated nutritional supplements in which he took a regimen of USANA pills, protein bars, powder drinks and psyllium fiber as recommended by the company's online evaluation. Cloud took a blood test before starting the products to measure levels of calcium, protein, sodium, cholesterol, glucose, and other substances, and was then tested again five months after starting the supplement regimen, which included 3,000 pills at a cost of $1,200. The follow-up test revealed a change in only two values; a 75% increase in vitamin D levels (attributed to the vitamin D3 supplement Cloud had been taking) and a 28 mg/dl increase in high-density lipoprotein, which could not be accounted for. Cloud also experienced a placebo response where that act of taking the supplements made him feel more vigorous despite no physiological reasons being present. This response also led to a 10-lb weight gain, as the belief that he was more vigorous led him to make poorer dietary decisions—a phenomenon referred to as the "licensing effect".

New Zealand government statistician for the Commerce Commission, Murray H. Smith, who served as an expert witness in every pyramid scheme case brought by the Commission preceding 10 years, opined in 2008 that very few USANA distributors are likely to become wealthy, and stated, "you can make a very strong argument that this could be a pyramid scheme." When asked by the National Business Review to review the firm's business structure and compensation plan, it was Smith's opinion, from a statistical not legal standpoint, that the firm demonstrated a number of characteristics commonly occurring in pyramid schemes including that most members recoup less than what they pay to participate; that those at the top of the structure are more likely to make more than those on the bottom of the structure; and that as the company grows it will become harder to recruit others. Smith also noted the company's significant turnover in distributors making it necessary to continually recruit.

Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗

Wikidata ↗

sektörConsumer products endüstriConsumer products çalışanlar1.570 ülkeUS

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

06
Gelir$925M
2016-12-31 → 2026-01-03
Hisse Başına Kâr$0.58
2016-12-31 → 2026-01-03
Serbest Nakit Akışı$9M
2016-12-31 → 2026-01-03
Net kar marjı-4.2%
2016-12-31 → 2026-01-03
Değerleme ve Oranlar 07–12

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Metrik 5 Yıllık trend USNA 5Y ort. Akran Ortalaması Sonuç
P/E (TTM) -7.15Y ort. ≈19.7 ≈19.7 · ·
F/S (TTM) 0.35Y ort. ≈1.0 ≈1.0 1.2 Düşük değerli
F/D (MRQ) 0.55Y ort. ≈2.3 ≈2.3 2.4 Düşük değerli
Fiyat / Serbest Nakit Akışı (TTM) -16.85Y ort. ≈20.5 ≈20.5 · ·
Fiyat / Nakit Akışı (TTM) -157.25Y ort. ≈13.5 ≈13.5 16.8 Adil değer
Fiyat / Maddi Defter Değeri (MRQ) 0.75Y ort. ≈3.0 ≈3.0 · ·

Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.

değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

14
Ort. Sürpriz -21.9%
Sonraki Rapor Eki 19, 2026
DönemRaporEPS GerçekEPS TahminSürpriz
30 Haziran 2026 Tem 20, 2026 $-0.07 $0.44 -116.0%
31 Mart 2026 $0.61 $0.45 35.9%
31 Aralık 2025 $0.60 $0.42 43.5%
30 Eylül 2025 $-0.15 $0.48 -131.3%
30 Haziran 2025 $0.74 $0.55 34.4%
31 Mart 2025 $0.73 $0.71 2.2%

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

15
Gelir Tablosu 18
Metrik Eğilim 202520242023202220212020201920182017201620152014
Revenue $925M$855M$921M$999M$1.19B$1.13B$1.06B$1.19B$1.05B$1.01B$918M$790M
Cost of Revenue $201M$161M$177M$194M$218M$209M$188M$201M$179M$180M$160M$141M
Gross Profit $724M$693M$744M$805M$969M$926M$873M$989M$868M$826M$759M$650M
R&D Expense $11M$12M$11M$12M$11M$11M$10M$10M$9M$9M$6M$5M
SG&A Expense $337M$263M$257M$262M$279M$261M$268M$275M$265M$234M$209M$185M
Operating Expenses $687M$627M$651M$697M$798M$749M$727M$800M$735M$687M$617M$534M
Operating Income $37M$66M$93M$108M$170M$176M$146M$188M$133M$139M$142M$116M
Interest Expense ··$262.0K$192.0K$57.0K$507.0K$66.0K$36.0K$46.0K$444.0K$15.0K$129.0K
Interest Income $2M$11M$10M$4M$3M$3M$5M$4M$2M$1M$1M$500.0K
Other Non-op $3M$-1M$7.0K$-3M$-2M$-571.0K$-335.0K$-1M$-3.0K$-1M$-174.0K$-820.0K
Pretax Income $42M$76M$102M$109M$171M$178M$150M$192M$135M$139M$143M$116M
Income Tax $30M$34M$39M$39M$54M$53M$50M$65M$72M$39M$48M$39M
Net Income $11M$42M$64M$69M$117M$125M$101M$126M$63M$100M$95M$77M
EPS (Basic) $0.58$2.20$3.31$3.60$5.78$5.89$4.44$5.24$2.57$4.14$3.72$2.90
EPS (Diluted) $0.58$2.19$3.30$3.59$5.73$5.86$4.41$5.12$2.53$3.99$3.59$2.80
Shares (Basic) 18,535,00019,103,00019,250,00019,254,00020,146,00021,156,00022,644,00024,105,00024,349,00024,185,00025,460,00026,443,000
Shares (Diluted) 18,574,00019,162,00019,345,00019,310,00020,343,00021,256,00022,818,00024,642,00024,708,00025,047,00026,355,00027,377,000
EBITDA $70M$81M$106M$121M$183M$190M$161M$205M$149M$152M$152M$125M
Bilanço 26
Metrik Eğilim 202520242023202220212020201920182017201620152014
Cash & Equivalents $158M$182M$330M$288M$240M$312M$235M$214M$247M$176M$143M$111M
Receivables $4M···········
Inventory $103M$70M$61M$67M$98M$90M$69M$82M$63M$65M$66M$45M
Prepaid Expense $23M$28M$26M$29M$27M$23M$26M$33M$30M$37M$35M$35M
Other Current Assets $5M$5M$6M$7M$4M$5M$5M$7M$5M$6M$5M$6M
Current Assets $288M$279M$418M$384M$365M$425M$329M$392M$340M$278M$244M$191M
PP&E (Net) $94M$95M$100M$98M$102M$100M$95M$92M$103M$101M$88M$71M
PP&E (Gross) ··$212M$210M$211M$199M$181M$178M$177M$164M$120M$114M
Accum. Depreciation $135M$130M$129M$125M$122M$116M$105M$96M$86M$76M$71M$64M
Goodwill $138M$144M$17M$17M$18M$17M$17M$17M$17M$17M$17M$18M
Intangibles $133M$152M$30M$32M$30M$31M$30M$32M$35M$34M$38M$41M
Other Non-current Assets $62M$59M$55M$55M$58M$62M$43M$18M$21M$22M$25M$24M
Total Assets $743M$748M$633M$597M$578M$641M$517M$554M$519M$471M$423M$351M
Accounts Payable $17M$12M$10M$11M$14M$18M$13M$10M$12M$9M$10M$8M
Accrued Liabilities $10M$14M$10M·········
Current Liabilities $129M$140M$119M$144M$161M$168M$136M$149M$141M$138M$131M$109M
Capital Leases $12M$10M$5M$8M$10M·$17M·····
Deferred Tax $5M$4M$5M$4M$7M$12M$10M$13M$14M$5M$10M$11M
Other Non-current Liabilities $23M$18M$12M$14M$14M$19M$19M$1M$1M$1M$1M$1M
Total Liabilities $157M$162M$136M·········
Common Stock $18.0K$19.0K$19.0K$19.0K$19.0K$21.0K$22.0K$24.0K$24.0K$24.0K$25.0K$13.0K
Retained Earnings $466M$479M$445M$392M$345M$383M$306M$330M$288M$265M$215M$166M
AOCI $-16M$-23M$-14M$-13M$458.0K$-4M$-14M$-10M$-1M$-12M$-4M$2M
Stockholders' Equity $533M$532M$497M$434M$395M$442M$352M$391M$363M$325M$281M$230M
Liabilities + Equity $743M$748M$633M$597M$578M$641M$517M$554M$519M$471M$423M$351M
Shares Outstanding 18,281,00019,064,00019,130,00019,206,00019,393,00021,038,00021,655,00023,567,00024,024,00024,485,00024,976,00025,266,000
Nakit Akışı 16
Metrik Eğilim 202520242023202220212020201920182017201620152014
D&A $33M$15M$13M$13M$13M$14M$15M$17M$16M$13M$10M$9M
Stock-based Comp $14M$15M$15M$13M$14M$14M$16M$15M$15M$17M$11M$10M
Deferred Tax $-7M$-7M$-3M$-7M$-3M$-2M$-4M$607.0K$19M$-4M$-3M$-1M
Amort. of Intangibles $19M$2M$2M$2M$1M$1M$1M$2M$1M$2M$900.0K$431.0K
Restructuring $6M$0$0·········
Other Non-cash $-28M$-3M$-18M$15M$-20M$10M$-442.0K$-7M$10M$11M$-2M$11M
Operating Cash Flow $22M$61M$71M$104M$121M$160M$127M$152M$124M$137M$111M$105M
CapEx $14M$10M$14M$10M$13M$15M$17M$11M$13M$33M$24M$20M
Investing Cash Flow $-10M$-213M$-12M$-12M$-14M$-34M$47M$-69M$-13M$-32M$-25M$-16M
Stock Repurchased $28M$9M$12M$25M$178M$57M$150M$105M$50M$65M$61M$139M
Net Stock Activity $-28M$-9M$-12M$-25M$-178M$-57M$-150M$-105M$-50M$-65M$-61M$-139M
Financing Cash Flow $-41M$10M$-14M$-30M$-181M$-59M$-152M$-105M$-50M$-65M$-49M$-113M
Net Change in Cash $-23M$-149M$42M$48M$-72M$78M$20M$-33M$72M$32M$32M$-26M
Taxes Paid $37M$40M$42M·········
Free Cash Flow $9M$51M$56M$94M$108M$145M$110M$141M$111M$104M$88M$85M
Levered FCF ··$56M$93M$108M$145M$110M$141M$111M$104M$88M$85M
Kârlılık 8
Metrik Eğilim 202520242023202220212020201920182017201620152014
Gross Margin 78.3%81.1%80.8%80.6%81.6%81.6%82.3%83.1%82.9%82.1%82.6%82.2%
Operating Margin 4.0%7.8%10.1%10.8%14.3%15.6%13.8%15.8%12.7%13.8%15.4%14.7%
Net Margin 1.2%4.9%6.9%6.9%9.8%11.0%9.5%10.6%6.0%9.9%10.3%9.7%
Pretax Margin 4.5%8.9%11.1%10.9%14.4%15.7%14.2%16.1%12.9%13.8%15.5%14.6%
EBITDA Margin 7.6%9.5%11.5%12.1%15.4%16.8%15.2%17.2%14.2%15.1%16.5%15.8%
ROA 1.4%6.1%10.4%11.8%19.1%21.5%18.8%23.5%12.6%22.4%24.5%21.3%
ROE 2.0%7.9%13.2%16.4%29.3%30.0%30.2%30.5%17.2%33.0%37.0%31.2%
ROIC 1.9%6.9%11.7%15.8%29.4%28.0%27.8%31.7%16.9%30.8%33.5%33.4%
Likidite ve Solventlik 3
Metrik Eğilim 202520242023202220212020201920182017201620152014
Current Ratio 2.22.03.52.72.32.52.42.62.42.01.91.8
Quick Ratio 1.21.32.82.01.51.91.71.41.81.31.11.0
Interest Coverage ··355.2560.52985.8348.12215.05232.02880.5312.29444.1900.0
Verimlilik 2
Metrik Eğilim 202520242023202220212020201920182017201620152014
Asset Turnover 1.21.21.51.71.92.02.02.22.12.32.42.2
Inventory Turnover 2.32.52.72.32.32.22.52.82.82.82.93.0
Hisse Başına 5
Metrik Eğilim 202520242023202220212020201920182017201620152014
Book Value / Share $29.16$27.91$25.99$22.62$20.37$20.99$16.24$16.60$15.12$13.29$22.49$18.22
Revenue / Share $49.81$44.59$47.61$51.71$58.32$53.38$46.49$48.26$42.39$40.17$69.70$57.74
Cash Flow / Share $1.20$3.18$3.65$5.38$5.96$7.55$5.55$6.17$5.01$5.47$8.46$7.68
Cash / Share $8.66$9.53$17.27$15.02$12.37$14.83$10.84$9.09$10.29$7.18$11.47$8.80
EPS (TTM) $0.58$2.19$3.30$3.59$5.73$5.86$4.41$5.12$2.53$3.99$3.59$2.80
Büyüme Oranları 9
Metrik Eğilim 202520242023202220212020201920182017201620152014
Revenue YoY 8.3%-7.2%-7.8%-15.8%4.6%·······
Revenue CAGR 3Y -2.5%-10.4%-6.7%·········
Revenue CAGR 5Y -4.0%···········
EPS YoY -73.5%-33.6%-8.1%-37.4%-2.2%·······
EPS CAGR 3Y -45.5%-27.4%-17.4%·········
EPS CAGR 5Y -37.0%···········
Net Income YoY -74.4%-34.1%-8.0%-40.5%-6.5%·······
Net Income CAGR 3Y -46.3%-28.8%-20.0%·········
Net Income CAGR 5Y -38.7%···········
Değerleme (TTM) 10
Metrik Eğilim 202520242023202220212020201920182017201620152014
Revenue TTM $925M$855M$921M$999M$1.19B$1.13B$1.06B$1.19B$1.05B$1.01B$918M$790M
Net Income TTM $11M$42M$64M$69M$117M$125M$101M$126M$63M$100M$95M$77M
Market Cap $355M$680M$1.03B$1.02B$1.96B$1.62B$1.73B$2.71B$1.78B$1.50B$798M$646M
P/E 33.516.316.214.817.713.218.122.529.315.317.818.3
P/S 0.40.81.11.01.71.41.62.31.71.50.90.8
P/B 0.71.32.12.45.03.74.96.94.94.62.82.8
P / Tangible Book 1.42.92.32.75.74.1······
P / Cash Flow 15.911.214.59.816.210.113.717.814.410.97.26.1
P / FCF 41.713.418.310.918.111.215.719.316.114.49.17.6
Earnings Yield 3.0%6.1%6.2%6.8%5.7%7.6%5.5%4.5%3.4%6.5%5.6%5.5%

En son dönem solda · null değerler · olarak gösterilir

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

16
Metrik 2026-01-032024-12-282023-12-302022-12-312022-01-01
Gelir $925M $855M $921M $999M $1.19B
Brüt Kâr Marjı % 78.3% 81.1% 80.8% 80.6% 81.6%
Faaliyet Kâr Marjı % 4.0% 7.8% 10.1% 10.8% 14.3%
Net Gelir $11M $42M $64M $69M $117M
Seyreltilmiş Hisse Başı Kâr $0.58 $2.19 $3.30 $3.59 $5.73

Kurumsal Sahipler (13F) 151 dosya · $260.7M toplam · Tarih itibarıyla 30 Eylül 2026

17

Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.

Sahipler 151
Tutulan Değer $260.7M
Yeni pozisyonlar 25
Çıkan pozisyonlar 17
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
Yeni pozisyonlar Çıkan pozisyonlar Artırıldı Azaldı Net hisse senedi değişimi
25 (-5 önceki Ç'ye göre) 17 (+8 önceki Ç'ye göre) 60 (+21 önceki Ç'ye göre) 30 (-19 önceki Ç'ye göre) +1.2M

Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.

Kurum Değer Hisse senetleri % izlenen 13F'nin Tür
BlackRock, Inc. $33.181.935 1.554.189 12,73% Hisse senetleri
PZENA INVESTMENT MANAGEMENT LLC $25.739.282 1.205.587 9,87% Hisse senetleri
RENAISSANCE TECHNOLOGIES LLC $20.464.402 958.520 7,85% Hisse senetleri
VANGUARD GROUP INC $18.340.623 934.316 7,03% Hisse senetleri
DIMENSIONAL FUND ADVISORS LP $17.878.705 837.426 6,86% Hisse senetleri
Nantahala Capital Management, LLC $17.295.080 810.074 6,63% Hisse senetleri
VANGUARD CAPITAL MANAGEMENT LLC $10.405.350 487.370 3,99% Hisse senetleri
Creative Planning $8.923.681 417.971 3,42% Hisse senetleri
AQR CAPITAL MANAGEMENT LLC $8.712.637 408.086 3,34% Hisse senetleri
VANGUARD PORTFOLIO MANAGEMENT LLC $7.758.099 363.377 2,98% Hisse senetleri
GEODE CAPITAL MANAGEMENT, LLC $6.047.019 283.165 2,32% Hisse senetleri
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $5.811.641 272.208 2,23% Hisse senetleri
STATE STREET CORP $5.577.474 261.240 2,14% Hisse senetleri
Nuveen, LLC $5.112.835 239.477 1,96% Hisse senetleri
AMERICAN CENTURY COMPANIES INC $3.999.880 187.348 1,53% Hisse senetleri
JACOBS LEVY EQUITY MANAGEMENT, INC $3.855.105 180.567 1,48% Hisse senetleri
TWO SIGMA INVESTMENTS, LP $3.533.724 165.514 1,36% Hisse senetleri
MORGAN STANLEY $3.509.150 164.363 1,35% Hisse senetleri
D. E. Shaw & Co., Inc. $3.348.427 156.835 1,28% Hisse senetleri
Allianz Asset Management GmbH $3.040.219 142.399 1,17% Hisse senetleri
BRIDGEWAY CAPITAL MANAGEMENT, LLC $2.949.567 138.153 1,13% Hisse senetleri
ALGERT GLOBAL LLC $2.813.033 131.758 1,08% Hisse senetleri
GOLDMAN SACHS GROUP INC $2.631.750 123.267 1,01% Hisse senetleri
UBS Group AG $2.474.166 115.886 0,95% Hisse senetleri
LAZARD ASSET MANAGEMENT LLC $2.077.590 97.311 0,80% Hisse senetleri
NORTHERN TRUST CORP $2.016.870 94.467 0,77% Hisse senetleri
AMERIPRISE FINANCIAL INC $1.552.893 72.735 0,60% Hisse senetleri
VANGUARD FIDUCIARY TRUST CO $1.549.540 72.578 0,59% Hisse senetleri
Vanguard Global Advisers, LLC $1.514.569 70.940 0,58% Hisse senetleri
Empowered Funds, LLC $1.499.902 70.253 0,58% Hisse senetleri
TWO SIGMA ADVISERS, LP $1.289.691 65.700 0,49% Hisse senetleri
Bank of New York Mellon Corp $1.104.521 51.734 0,42% Hisse senetleri
Quantinno Capital Management LP $1.072.261 50.223 0,41% Hisse senetleri
BANK OF AMERICA CORP /DE/ $967.539 45.318 0,37% Hisse senetleri
ROYCE & ASSOCIATES LP $884.039 41.407 0,34% Hisse senetleri
DEUTSCHE BANK AG\ $821.975 38.500 0,32% Hisse senetleri
Assenagon Asset Management S.A. $815.848 38.213 0,31% Hisse senetleri
BARCLAYS PLC $777.141 36.400 0,30% Hisse senetleri
STRS OHIO $723.765 33.900 0,28% Hisse senetleri
Skopos Labs, Inc. $673.696 38.563 0,26% Hisse senetleri
HSBC HOLDINGS PLC $672.758 31.960 0,26% Hisse senetleri
Invesco Ltd. $670.775 31.418 0,26% Hisse senetleri
SEI INVESTMENTS CO $641.513 30.047 0,25% Hisse senetleri
XTX Topco Ltd $625.320 29.289 0,24% Hisse senetleri
CITADEL ADVISORS LLC $575.617 26.961 0,22% Hisse senetleri
MILLENNIUM MANAGEMENT LLC $570.728 26.732 0,22% Hisse senetleri
Verdad Advisers, LP $556.552 26.068 0,21% Hisse senetleri
Inspire Investing, LLC $512.954 29.362 0,20% Hisse senetleri
Sanctuary Advisors, LLC $497.113 23.284 0,19% Hisse senetleri
Man Group plc $489.854 22.944 0,19% Hisse senetleri

Tüm 151 kurumsal sahibi göster →

Aktivistler ve %5+ sahipler 3 pozisyon

18

SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.

Başvuru sahibi Dosyalandı Hisse Durum Amaç Başvuru
Gull Global Limited, Myron W. Wentz ×11 başvurular 30 Mart 2026 40,10% Değişiklik M&A / satış SEC
Gull Holdings, Ltd., Myron W. Wentz, David A. Wentz, Jacquelyn R. Wentz, Bryan Wentz, Annette Wentz, Paul & Jane Meyer Family Foundation, Paul James Meyer, Alice Jane Meyer, Centre Island Properties, Ltd., Waco Boys Club Foundation, Inc., L-K Marketing Group, LLC, Beagle Irrevocable Asset Trust 23 Mayıs 2008 · İlk başvuru · SEC
Paul & Jane Meyer Family Foundation 20 Mayıs 2008 · İlk başvuru Pasif yatırım SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Şirket yöneticileri 38 içeriden öğrenenler · 20 yöneticiler · 13 yönetim kurulu üyeleri

19
İçeriden Öğrenen Rol Son işlem Sahip olunan hisse senetleri Alımlar 12ay Satışlar 12ay Net 12ay
Jim Brown CEO & PRESIDENT 24 Temmuz 2025 M 16.934 0 0 $0
Doug G Iiekking CHIEF FINANCIAL OFFICER 27 Mayıs 2026 S 0 0 1 $-100.500
Jeffrey Yates Chief Financial Officer 28 Ekim 2010 M 0 0 0 $0
Deborah Woo President of Asia 08 Eylül 2016 M 1.479 0 0 $0
Fred W Cooper President and COO 28 Ekim 2010 M 0 0 0 $0
Walter Noot CHIEF OPERATING OFFICER 27 Şubat 2026 M 9.256 0 0 $0
Roy Truett Chief Operating Officer 27 Temmuz 2012 M 0 0 0 $0
Kathryn Michelle Armstrong CHIEF SCIENTIFIC OFFICER 25 Temmuz 2026 M 3.471 0 0 $0
Peter Benedict CHIEF INFORMATION OFFICER 25 Temmuz 2026 M 422 0 2 $-144.236
Brent Neidig CHIEF COMMERCIAL OFFICER 16 Haziran 2026 S 0 0 3 $-147.749
Paul A. Jones CHIEF PEOPLE OFFICER 08 Haziran 2026 S 0 0 2 $-231.984
Joshua Foukas CHIEF LEGAL OFFICER 07 Mayıs 2026 S 0 0 2 $-170.336
David Mulham Mulham CHIEF SALES OFFICER 10 Aralık 2025 S 8.387 0 1 $-18.333
Daniel A. Macuga CHIEF COMMUNICATIONS OFFICER 02 Mayıs 2024 S 0 0 0 $0
Robert A Sinnott CHIEF SCIENTIFIC OFFICER 05 Mart 2024 S 0 0 0 $0
James Bramble Chief Legal Officer and Sec 05 Şubat 2018 A 2.076 0 0 $0
Dave Wentz Co-C.E.O. 16 Ağustos 2016 M 384.883 0 0 $0
Rick Stambaugh Chief Information Officer 17 Aralık 2015 M 0 0 0 $0
Mark H Wilson E.V.P. of Sales 28 Ekim 2010 M 5.000 0 0 $0
Bradford Richardson E.V.P. of Asia Pacific 25 Şubat 2008 S 0 0 0 $0
Xia Ding Yönetim kurulu üyesi 23 Temmuz 2026 M 8.278 0 0 $0
John Turman Fleming Yönetim kurulu üyesi 23 Temmuz 2026 M 5.862 0 2 $-78.560
Peggie Pelosi Yönetim kurulu üyesi 23 Temmuz 2026 M 6.061 0 0 $0
Scott J Nixon Yönetim kurulu üyesi 23 Temmuz 2026 M 11.445 0 0 $0
Frederic J Winssinger Yönetim kurulu üyesi 23 Temmuz 2026 M 9.733 0 1 $-38.420
Timothy E Wood Yönetim kurulu üyesi 23 Temmuz 2026 M 11.837 0 0 $0
Gilbert A Fuller Yönetim kurulu üyesi 23 Temmuz 2026 M 1.632 0 3 $-60.414
Robert Auciaux Yönetim kurulu üyesi 09 Mayıs 2022 M 8.092 0 0 $0
Feng Peng Yönetim kurulu üyesi 28 Nisan 2021 M 755 0 0 $0
Myron W. Wentz Yönetim kurulu üyesi 04 Şubat 2019 S 9.865.614 0 0 $0
Jerry G Mcclain Yönetim kurulu üyesi 04 Mart 2016 M 0 0 0 $0
Ronald S Poelman Yönetim kurulu üyesi 08 Şubat 2016 A 0 0 0 $0
Denis E Waitley Yönetim kurulu üyesi 03 Kasım 2006 M 0 0 0 $0
Gull Global Limited 10% sahip 04 Şubat 2019 S 9.865.614 0 0 $0
GULL HOLDINGS LTD 10% sahip 01 Nisan 2015 J 6.491.110 0 0 $0
Kevin Guest · 27 Şubat 2026 M 45.381 0 0 $0
Donald R. Williams · 01 Mayıs 2017 A · 0 0 $0
Doug Braun · 16 Aralık 2015 M 0 0 0 $0

SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış

ETF sahipliği 22 ETF'ler tarafından tutuluyor

20

Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.

Fon Ağırlık Birimler Tarih itibarıyla Kaynak
VFVA · VANGUARD WELLINGTON FUND 0,11% 45.046 SH 19 Ağustos 2026 Günlük
EBIT · Harbor ETF Trust 0,07% 367 NS 31 Temmuz 2026 N-PORT
IWC · iShares Trust 0,04% 37.870 SH 11 Eylül 2026 Günlük
VDC · VANGUARD WORLD FUND 0,03% 128.565 SH 19 Ağustos 2026 Günlük
VTWV · VANGUARD SCOTTSDALE FUNDS 0,02% 9.639 SH 19 Ağustos 2026 Günlük
DFSV · Dimensional ETF Trust 0,02% 67.386 NS 31 Temmuz 2026 N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust 0,01% 23.709 SH 02 Ekim 2026 Günlük
DFAT · Dimensional ETF Trust 0,01% 67.428 NS 31 Temmuz 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0,01% 64.278 SH 19 Ağustos 2026 Günlük
RSSL · Global X Funds 0,01% 5.337 NS 31 Temmuz 2026 N-PORT
OMFS · Invesco Exchange-Traded Self-Indexe… 0,01% 1.189 SH 01 Ekim 2026 Günlük
DFAS · Dimensional ETF Trust 0,01% 42.099 NS 31 Temmuz 2026 N-PORT
IWM · iShares Trust 0,01% 283.783 SH 11 Eylül 2026 Günlük
DFAC · Dimensional ETF Trust 0,00% 19.278 NS 31 Temmuz 2026 N-PORT
ITOT · iShares Trust 0,00% 22.756 SH 11 Eylül 2026 Günlük
IWV · iShares Trust 0,00% 3.720 SH 03 Eylül 2026 Günlük
DFUS · Dimensional ETF Trust 0,00% 1.784 NS 31 Temmuz 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0,00% 124.681 SH 19 Ağustos 2026 Günlük
VTI · VANGUARD INDEX FUNDS 0,00% 350.035 SH 19 Ağustos 2026 Günlük
VTHR · VANGUARD SCOTTSDALE FUNDS 0,00% 790 SH 19 Ağustos 2026 Günlük
IWN · iShares Trust · 101.470 SH 11 Eylül 2026 Günlük
SMLF · iShares Trust · 22.964 SH 11 Eylül 2026 Günlük

USNA Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

21
derecelendirme · 6 analist SAT
Medyan hedef $25.00 +68,7%
0 0,0% Güçlü Al
0 0,0% Al
3 50,0% Tut
1 16,7% Sat
2 33,3% Güçlü Sat

12 Aylık Fiyat Hedefi

1 analist · 2026-10-01

Ortalama hedef $25.00 +68,7%

Düşük$25.00 Ortalama$25.00 Yüksek$25.00

Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı

22

Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.

Hisse Sembolü Piyasa Değeri P/E Gelir YoY Net Kar Marjı ROE Brüt Kar Marjı
USNA $355M 33.5 8.3% 1.2% 2.0% 78.3%
EPC $946M 38.4 -1.3% 1.1% 1.7% 41.6%
BRBR $4.39B 21.6 16.1% 9.3% -72.0% 33.3%
HNST $291M -18.4 -1.9% -4.2% -8.8% 33.3%
NUS · 3.0 -14.3% 10.8% 22.0% 69.5%
NAGE $507M 31.8 29.9% 13.4% 24.7% 64.3%
NATR $378M 20.4 5.7% 4.1% 12.0% 72.4%
MED $117M -6.3 -36.0% -4.8% -9.0% 71.3%

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

26

Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.

Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.

Kaynak: SEC 10-Q dosyalandı Ağu 13, 2026